Skip to main content
Top

Current Diabetes Reports

Issue 3/2017

Content (6 Articles)

Microvascular Complications—Nephropathy (M Afkarian, Section Editor)

Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease

Alice Sabatino, Giuseppe Regolisti, Carmela Cosola, Loreto Gesualdo, Enrico Fiaccadori

Microvascular Complications—Nephropathy (M Afkarian, Section Editor)

The Role of Endoplasmic Reticulum Stress in Diabetic Nephropathy

Ying Fan, Kyung Lee, Niansong Wang, John Cijiang He

Microvascular Complications—Nephropathy (M Afkarian, Section Editor)

Diet and Diabetic Kidney Disease: Plant Versus Animal Protein

Ranjani N. Moorthi, Colby J. Vorland, Kathleen M. Hill Gallant

Microvascular Complications—Nephropathy (M Afkarian, Section Editor)

Caveolin-1 in the Pathogenesis of Diabetic Nephropathy: Potential Therapeutic Target?

Richard Van Krieken, Joan C. Krepinsky

Open Access Diabetes Epidemiology (NM Maruthur, Section Editor)

Arsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links?

Rowan Beck, Miroslav Styblo, Praveen Sethupathy

Immunology, Transplantation, and Regenerative Medicine (L Piemonti and V Sordi, Section Editors)

Porcine Islet Xenografts: a Clinical Source of ß-Cell Grafts

Bassem F. Salama, Gregory S. Korbutt

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.